Entering text into the input field will update the search result below

Where Will Edwards Lifesciences Stock Be In 4 Years?


  • Edwards Lifesciences has had an impeccable record of steadily rising earnings for more than two decades.
  • However, the market has typically valued the stock at a level that reflects this growth.
  • In this article, I will use Edwards' historical earnings to estimate what sort of returns the stock is likely to produce over the next four years.
  • I do much more than just articles at The Cyclical Investor’s Club: Members get access to model portfolios, regular updates, a chat room, and more. Learn More »

Wooden seesaw scale empty on wooden sphere on wood table with wording VALUE and PRICE balancing



This will be an article that estimates Edwards Lifesciences (NYSE:EW) stock's medium-term returns using an earnings valuation technique. Because I prefer to focus mostly on the numbers and let those guide the return estimates for stocks rather than

Data by YCharts

Data by YCharts

Edwards Lifesciences long-term earnings trend

FAST Graphs

Data by YCharts

Edwards Lifesciences Earnings growth rate and earnings yield

FAST Graphs

If you have found my strategies interesting, useful, or profitable, consider supporting my continued research by joining the Cyclical Investor's Club. It's only $30/month, and it's where I share my latest research and exclusive small-and-midcap ideas. Two-week trials are free.

This article was written by

Cory Cramer profile picture
One-of-kind research using historical cycles to identify tops and bottoms

My analysis focuses on the cyclical nature of individual companies and of markets in general. I've developed a unique approach to estimating the fair value of cyclical stocks, and that approach allows me to more accurately buy near the bottom of the cycle.

My academic background is in political science and I hold a Bachelor's Degree and a Master's Degree in political theory from Iowa State University. I was awarded a Graduate Research Excellence Award in 2015 for my research on conservatism.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of TFLO, META either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.